Phase 4
N=60
A Comparison of Naropin and Ketorolac for Postoperative Analgesia After Total Knee Arthroplasty
Postoperative Pain
Bottom Line
View on ClinicalTrials.gov: NCT00868348 ↗Enrolled (actual)
60
Serious AEs
3.3%
Results posted
Mar 2014
Primary outcome: Primary: Morphine Consumption — 48.75; 10 mg
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Ketorolac (Drug); Saline (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Aarhus
- Primary completion
- Jun 2011
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Morphine Consumption |
48.75; 10 | — |
| SECONDARY Time to First i.v. Patient Controlled Analgesia (PCA) Morphine Request |
223; 490 | — |
| SECONDARY Pain Intensity Scores During Walking |
64; 29 | — |
| SECONDARY Home Readiness |
3; 2 | — |
| SECONDARY Length of Hospital Stay |
3; 3 | — |
| SECONDARY Pain Intensity During Daily Activity |
4; 3 | — |
Summary
The purpose of this study is to determine wether ketorolac is effective in the treatment of postoperative pain after total knee arthroplasty
Eligibility Criteria
Inclusion Criteria
- Total knee arthroplasty
- Age > 18
- Tolerance for study drugs
- Written informed consent
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT00868348). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.